Press Release

<< Back
May 12, 2015 at 7:00 AM EDT

Verastem to Present at 2015 UBS Global Health Care Conference

BOSTON--(BUSINESS WIRE)--May 12, 2015-- Verastem, Inc. (NASDAQ: VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that the company will present at the 2015 UBS Global Healthcare Conference on Tuesday, May 19 at 1:30 p.m. ET at the Sheraton New York Times Square Hotel in New York City.

A live webcast of the presentation will be available on the company's website at http://phx.corporate-ir.net/phoenix.zhtml?c=250749&p=irol-calendar. An archived presentation will be available for 90 days.

About Verastem, Inc.

Verastem, Inc. (NASDAQ:VSTM) is discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is developing small molecule inhibitors of signaling pathways that are critical to cancer stem cell survival and proliferation: FAK and PI3K/mTOR. For more information, please visit www.verastem.com.

Source: Verastem, Inc.

Verastem, Inc.
Brian Sullivan, 781-292-4214
bsullivan@verastem.com

Investor Contact

getty
John Doyle

VP Investor Relations & Finance
781.292.4279
jdoyle@verastem.com

Joe Rayne

Argot Partners
617.340.6075
joseph@argotpartners.com